keyword
https://read.qxmd.com/read/38616528/the-growth-promotion-in-endophyte-symbiotic-plants-does-not-penalise-the-resistance-to-herbivores-and-bacterial-microbiota
#21
JOURNAL ARTICLE
Wei Zhang, Pedro E Gundel, Ruy Jáuregui, Stuart D Card, Wade J Mace, Richard D Johnson, Daniel A Bastías
A trade-off between growth and defence against biotic stresses is common in plants. Fungal endophytes of the genus Epichloë may relieve this trade-off in their host grasses since they can simultaneously induce plant growth and produce antiherbivore alkaloids that circumvent the need for host defence. The Epichloë ability to decouple the growth-defence trade-off was evaluated by subjecting ryegrass with and without Epichloë endophytes to an exogenous treatment with gibberellin (GA) followed by a challenge with Rhopalosiphum padi aphids...
April 14, 2024: Plant, Cell & Environment
https://read.qxmd.com/read/38616111/joint-association-of-lipoprotein-a-and-a-family-history-of-coronary-artery-disease-with-the-cardiovascular-outcomes-in-patients-with-chronic-coronary-syndrome
#22
JOURNAL ARTICLE
Hui-Hui Liu, Sha Li, Yan Zhang, Yuan-Lin Guo, Cheng-Gang Zhu, Na-Qiong Wu, Ying Gao, Rui-Xia Xu, Qian Dong, Jian-Jun Li
AIM: No data are currently available regarding the association between Lp(a) and the cardiovascular outcomes in patients with coronary artery disease (CAD) according to their family history (FHx) of CAD. This study aimed to evaluate the significance of Lp(a) in predicting major adverse cardiovascular events (MACEs) in patients with chronic coronary syndrome (CCS) with or without FHx. METHODS: A total of 6056 patients with CCS were enrolled. Information on FHx was collected, and the plasma Lp(a) levels were measured...
April 13, 2024: Journal of Atherosclerosis and Thrombosis
https://read.qxmd.com/read/38614140/assessment-of-fitness-for-open-repair-in-patients-with-infrarenal-abdominal-aortic-aneurysms
#23
JOURNAL ARTICLE
Mitri K Khoury, Micah A Thornton, Matthew J Eagleton, Sunita D Srivastava, Nikolaos Zacharias, Anahita Dua, Abhisekh Mohapatra
INTRODUCTION: Endovascular aortic repair (EVAR) was originally designed as a treatment modality for patients with abdominal aortic aneurysms (AAAs) deemed unfit for open repair. However, the definition of "unfit for open repair" is largely subjective and heterogenous. The purpose of this study was to compare patients deemed unfit for open repair who underwent EVAR to a matched cohort who underwent open repair for infrarenal AAAs. METHODS: The Vascular Quality Initiative (VQI) of the Society for Vascular Surgery (SVS) was queried for patients who underwent EVAR and open infrarenal AAA repair from 2003-2022...
April 11, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38613121/nutritional-status-and-recurrent-major-cardiovascular-events-following-acute-myocardial-infarction-a-follow-up-study-in-a-primary-percutaneous-coronary-intervention-center
#24
JOURNAL ARTICLE
Maria Czinege, Vasile-Bogdan Halațiu, Victoria Nyulas, Liliana-Oana Cojocariu, Bianca Ion, Violeta Mașca, Constantin Țolescu, Theodora Benedek
BACKGROUND: Acute myocardial infarction is often accompanied by malnutrition, which is associated with an imbalance between catabolic and anabolic processes. This ultimately leads to cardiac cachexia, which worsens the patient's prognosis. We aimed to assess the correlation between nutritional status, assessed using the controlling nutritional status (CONUT) score, and the rate of major cardiovascular adverse events (MACE). METHODS: The present investigation was a non-randomized, prospective, observational study in which 108 patients with acute myocardial infarction were included...
April 8, 2024: Nutrients
https://read.qxmd.com/read/38613095/bile-acids-and-risk-of-adverse-cardiovascular-events-and-all-cause-mortality-in-patients-with-acute-coronary-syndrome
#25
JOURNAL ARTICLE
Javier Mateu-Fabregat, Hamza Mostafa, Raul Sanchez-Gimenez, Óscar M Peiró, Gil Bonet, Anna Carrasquer, Georgios A Fragkiadakis, Alfredo Bardaji, Mònica Bulló, Christopher Papandreou
The relationship between bile acids (BAs) and adverse cardiovascular events following acute coronary syndrome (ACS) have been little investigated. We aimed to examine the associations of BAs with the risk of cardiovascular events and all-cause mortality in ACS. We conducted a prospective study on 309 ACS patients who were followed for 10 years. Plasma BAs were quantified by liquid chromatography coupled to tandem mass spectrometry. Cox regression analyses with elastic net penalties were performed to associate BAs with MACE and all-cause mortality...
April 5, 2024: Nutrients
https://read.qxmd.com/read/38612918/characterization-of-biomarkers-of-thrombo-inflammation-in-patients-with-first-diagnosed-atrial-fibrillation
#26
JOURNAL ARTICLE
Julian Friebel, Max Wegner, Leon Blöbaum, Philipp-Alexander Schencke, Kai Jakobs, Marianna Puccini, Emily Ghanbari, Stella Lammel, Tharusan Thevathasan, Verena Moos, Marco Witkowski, Ulf Landmesser, Ursula Rauch-Kröhnert
Patients with first-diagnosed atrial fibrillation (FDAF) exhibit major adverse cardiovascular events (MACEs) during follow-up. Preclinical models have demonstrated that thrombo-inflammation mediates adverse cardiac remodeling and atherothrombotic events. We have hypothesized that thrombin activity (FIIa) links coagulation with inflammation and cardiac fibrosis/dysfunction. Surrogate markers of the thrombo-inflammatory response in plasma have not been characterized in FDAF. In this prospective longitudinal study, patients presenting with FDAF ( n = 80), and 20 matched controls, were included...
April 8, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38610752/risk-of-mortality-and-cardiovascular-events-in-patients-with-chronic-obstructive-pulmonary-disease-treated-with-azithromycin-roxithromycin-clarithromycin-and-amoxicillin
#27
JOURNAL ARTICLE
Imane Achir Alispahic, Josefin Eklöf, Pradeesh Sivapalan, Alexander Ryder Jordan, Zitta Barrella Harboe, Tor Biering-Sørensen, Jens-Ulrik Stæhr Jensen
Background: Prior research has raised concerns regarding the use of macrolides and their association with an increased risk of cardiovascular events. Methods: We conducted a cohort study, where we explored the cardiovascular risks associated with the treatment of COPD patients using macrolide antibiotics-namely azithromycin, clarithromycin, and roxithromycin-with amoxicillin serving as a reference. The study focused on COPD patients in an outpatient setting and included a thorough 3-year follow-up. Patients were categorized into four groups based on their treatment...
March 29, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38610724/the-net-clinical-outcome-of-dual-pathway-inhibition-in-clinical-practice-the-xarelto-plus-acetylsalicylic-acid-treatment-patterns-and-outcomes-in-patients-with-atherosclerosis-registry
#28
JOURNAL ARTICLE
Alexander Breitenstein, Alain Gay, Kai Vogtländer, Keith A A Fox, Jan Steffel
Background : In the COMPASS trial, the combination of acetylsalicylic acid (ASA) plus 2.5 mg rivaroxaban twice daily (dual-pathway inhibition, DPI) has been shown to be superior to ASA monotherapy for the reduction in ischemic major adverse cardiovascular events (MACEs, i.e., cardiovascular death, stroke, or myocardial infarction). Methods : The international XATOA registry (Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis) is a prospective post-approval registry that investigates the cardiovascular outcomes of patients taking ASA plus 2...
March 28, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38609875/predictors-of-major-adverse-cardiac-and-cerebrovascular-events-after-percutaneous-coronary-intervention-in-older-adults-a-systematic-review-and-meta-analysis
#29
JOURNAL ARTICLE
Arash Jalali, Ali Hassanzadeh, Mohammad Sadeq Najafi, Sepehr Nayebirad, Mohadese Dashtkoohi, Zahra Karimi, Akbar Shafiee
AIM: We systematically reviewed and meta-analyzed the predictors of major adverse cardiac and cerebrovascular events (MACE/MACCE) in older adults who underwent PCI. METHODS: Three databases, PubMed, Embase, and Scopus, were searched for observational studies considering the out-of-hospital MACE/MACCE in adults ≥ 60 years old with coronary artery disease (acute or chronic) who underwent PCI. Studies were eligible if they had determined at least two statistically significant predictors of MACE/MACCE by multivariable analysis...
April 12, 2024: BMC Geriatrics
https://read.qxmd.com/read/38609322/risk-of-extended-major-adverse-cardiovascular-event-endpoints-with-tofacitinib-versus-tnf-inhibitors-in-patients-with-rheumatoid-arthritis-a-post-hoc-analysis-of-a-phase-3b-4-randomised-safety-study
#30
JOURNAL ARTICLE
Maya H Buch, Deepak L Bhatt, Christina Charles-Schoeman, Jon T Giles, Ted Mikuls, Gary G Koch, Steven Ytterberg, Edward Nagy, Hyejin Jo, Kenneth Kwok, Carol A Connell, Karim Richard Masri, Arne Yndestad
OBJECTIVES: Compare the risk of extended major adverse cardiovascular (CV) event (MACE) composite outcomes and component events in patients with rheumatoid arthritis (RA) treated with tofacitinib versus tumour necrosis factor inhibitors (TNFi) in Oral Rheumatoid Arthritis Trial (ORAL) Surveillance. METHODS: Patients with RA aged ≥50 years and with ≥1 additional CV risk factor received tofacitinib 5 mg or 10 mg two times per day or TNFi...
April 12, 2024: RMD Open
https://read.qxmd.com/read/38609042/intravascular-imaging-guided-percutaneous-coronary-intervention-in-patients-with-acute-myocardial-infarction-and-cardiogenic-shock
#31
JOURNAL ARTICLE
Hyun Sung Joh, Seung Hun Lee, Jinhwan Jo, Hyun Kuk Kim, Woo-Hyun Lim, Hack-Lyoung Kim, Jae-Bin Seo, Woo-Young Chung, Sang-Hyun Kim, Joo-Hee Zo, Myung-A Kim, Min Chul Kim, Ju Han Kim, Young Joon Hong, Young Keun Ahn, Myung Ho Jeong, Seung Ho Hur, Doo Il Kim, Kiyuk Chang, Hun Sik Park, Jang-Whan Bae, Jin-Ok Jeong, Yong Hwan Park, Kyeong Ho Yun, Chang-Hwan Yoon, Yisik Kim, Jin-Yong Hwang, Hyo-Soo Kim, David Hong, Woochan Kwon, Ki Hong Choi, Taek Kyu Park, Jeong Hoon Yang, Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Hyeon-Cheol Gwon, Joo Myung Lee
INTRODUCTION AND OBJECTIVES: There are no clinical data on the efficacy of intravascular imaging-guided percutaneous coronary intervention (PCI) compared with angiography-guided PCI in patients with acute myocardial infarction (AMI) and cardiogenic shock. The current study sought to evaluate the impact of intravascular imaging-guided PCI in patients with AMI and cardiogenic shock. METHODS: Among a total of 28 732 patients from the nationwide pooled registry of KAMIR-NIH (November, 2011 to December, 2015) and KAMIR-Ⅴ (January, 2016 to June, 2020), we selected a total of 1833 patients (6...
April 10, 2024: Revista Española de Cardiología
https://read.qxmd.com/read/38608997/rationale-and-design-for-the-randomized-placebo-controlled-double-blind-trial-studying-the-effect-of-single-antiplatelet-therapy-clopidogrel-versus-dual-antiplatelet-therapy-clopidogrel-acetylsalicylic-acid-on-the-occurrence-of-atherothrombotic-events-following
#32
JOURNAL ARTICLE
Emilien C J Wegerif, Çağdaş Ünlü, Manon I Generaal, Rutger van den Bor, Peter M van de Ven, Michiel L Bots, Gert J de Borst
RATIONALE: Antiplatelet therapy (APT) is the standard of care after endovascular revascularization (EVR) in patients with peripheral artery disease (PAD). APT aims to prevent both major adverse cardiovascular events (MACE) and major adverse limb events (MALE). Nonetheless, the rates of MACE and MALE after EVR remain high. In coronary artery and cerebrovascular disease, dual APT (DAPT)compared to acetylsalicylic acid alone has proven to reduce MACE without increasing the risk of major bleeding when applied for a restricted number of weeks...
April 10, 2024: American Heart Journal
https://read.qxmd.com/read/38607931/extracellular-vesicles-released-by-keratinocytes-regulate-melanosome-maturation-melanocyte-dendricity-and-pigment-transfer
#33
JOURNAL ARTICLE
Marie-Thérèse Prospéri, Cécile Giordano, Mireia Gomez-Duro, Ilse Hurbain, Anne-Sophie Macé, Graça Raposo, Gisela D'Angelo
Extracellular vesicles (EVs) facilitate the transfer of proteins, lipids, and genetic material between cells and are recognized as an additional mechanism for sustaining intercellular communication. In the epidermis, the communication between melanocytes and keratinocytes is tightly regulated to warrant skin pigmentation. Melanocytes synthesize the melanin pigment in melanosomes that are transported along the dendrites prior to the transfer of melanin pigment to keratinocytes. EVs secreted by keratinocytes modulate pigmentation in melanocytes [(A...
April 16, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38606889/atherosclerosis-evaluation-and-cardiovascular-risk-estimation-using-coronary-computed-tomography-angiography
#34
JOURNAL ARTICLE
Nick S Nurmohamed, Alexander R van Rosendael, Ibrahim Danad, Quyen Ngo-Metzger, Pam R Taub, Kausik K Ray, Gemma Figtree, Marc P Bonaca, Judith Hsia, Fatima Rodriguez, Alexander T Sandhu, Koen Nieman, James P Earls, Udo Hoffmann, Jeroen J Bax, James K Min, David J Maron, Deepak L Bhatt
Clinical risk scores based on traditional risk factors of atherosclerosis correlate imprecisely to an individual's complex pathophysiological predisposition to atherosclerosis and provide limited accuracy for predicting major adverse cardiovascular events (MACE). Over the past two decades, computed tomography scanners and techniques for coronary computed tomography angiography (CCTA) analysis have substantially improved, enabling more precise atherosclerotic plaque quantification and characterization. The accuracy of CCTA for quantifying stenosis and atherosclerosis has been validated in numerous multicentre studies and has shown consistent incremental prognostic value for MACE over the clinical risk spectrum in different populations...
April 12, 2024: European Heart Journal
https://read.qxmd.com/read/38606761/cardiovascular-risk-in-patients-with-treated-isolated-diastolic-hypertension-and-isolated-low-diastolic-blood-pressure
#35
JOURNAL ARTICLE
Wei-Lun Chang, Ying-Fan Chen, Yu-Hsuan Lee, Ming-Neng Shiu, Po-Yin Chang, Chao-Yu Guo, Chi-Jung Huang, Chern-En Chiang, Chen-Huan Chen, Shao-Yuan Chuang, Hao-Min Cheng
BACKGROUND: The prognosis of high or markedly low diastolic blood pressure (DBP) with normalized on-treatment systolic blood pressure on major adverse cardiovascular events (MACEs) is uncertain. This study examined whether treated isolated diastolic hypertension (IDH) and treated isolated low DBP (ILDBP) were associated with MACEs in patients with hypertension. METHODS AND RESULTS: A total of 7582 patients with on-treatment systolic blood pressure <130 mm Hg from SPRINT (Systolic Blood Pressure Intervention Trial) were categorized on the basis of average DBP: <60 mm Hg (n=1031; treated ILDBP), 60 to 79 mm Hg (n=5432), ≥80 mm Hg (n=1119; treated IDH)...
April 12, 2024: Journal of the American Heart Association
https://read.qxmd.com/read/38606610/prognostic-value-of-myocardial-flow-reserve-versus-corrected-myocardial-flow-reserve-in-patients-without-obstructive-coronary-artery-disease
#36
JOURNAL ARTICLE
Daniel M Huck, Brittany N Weber, Jenifer M Brown, Diana Lopez, Jon Hainer, Ron Blankstein, Sharmila Dorbala, Sanjay Divakaran, Marcelo F Di Carli
BACKGROUND: Myocardial flow reserve (MFR) by positron emission tomography (PET) is a validated measure of cardiovascular risk. Elevated resting rate pressure product (RPP = heart rate x systolic blood pressure) can cause high resting myocardial blood flow (MBF), resulting in reduced MFR despite normal/near-normal peak stress MBF. When resting MBF is high, it is not known if RPP-corrected MFR (MFRcorrected) helps reclassify CV risk. We aimed to study this question in patients without obstructive coronary artery disease (CAD)...
March 29, 2024: Journal of Nuclear Cardiology
https://read.qxmd.com/read/38604747/safety-and-effectiveness-of-glycoprotein-iib-iiia-inhibitors-in-acute-coronary-syndromes-insights-from-the-spum-acs-study
#37
JOURNAL ARTICLE
Francesco Bruno, Florian A Wenzl, Ovidio De Filippo, Simon Kraler, Federico Giacobbe, Marco Roffi, Olivier Muller, Lorenz Räber, Christian Templin, Gaetano Maria De Ferrari, Fabrizio D'Ascenzo, Thomas F Lüscher
AIMS: Data on Glycoprotein IIb/IIIa inhibitors (GPI) use in real world ACS patients following the introduction of potent P2Y12 inhibitors and newer generation stents are scant. Here, we aimed to assess the utilization, effectiveness, and safety of GPI in a large prospective multi-centre cohort of contemporary ACS patients. METHODS AND RESULTS: SPUM-ACS prospectively recruited patients presenting with ACS between 2009 and 2017. The primary endpoint of the present study was major adverse cardiovascular events (MACE), a composite of all-cause death, non-fatal myocardial infarction (MI) and non-fatal stroke at one year...
April 11, 2024: European Heart Journal. Cardiovascular Pharmacotherapy
https://read.qxmd.com/read/38604320/management-of-depth-to-achieve-timely-arterio-venous-fistula-utilization
#38
JOURNAL ARTICLE
Tracy J Cheun, Joseph P Hart, Mark G Davies
BACKGROUND: Failure to achieve timely arteriovenous fistulae (AVF) utilization due to excessive depth (>6mm) remains an ongoing concern for dialysis access. This study evaluates the outcomes of radio cephalic (RCF) and brachiocephalic (BCF) fistula elevation required for access utilization. METHODS: A retrospective review of all patients undergoing first-time autologous access over 10 years was undertaken. RCF and BCF were analyzed, and cases of initial access failure due to depth alone were selected for study...
April 9, 2024: Journal of Vascular Surgery
https://read.qxmd.com/read/38601367/comparison-of-effectiveness-of-high-dose-statin-monotherapy-with-combination-of-statin-and-ezetimibe-to-prevent-cardiovascular-events-in-patients-with-acute-coronary-syndrome-a-systematic-review-and-meta-analysis
#39
REVIEW
Nanush Damarpally, Tanya Sinha, Michelle Maricela Nunez, Manisha Guntha, Thin M Soe, Sandipkumar S Chaudhari, Roba A Ibrahim, Shamsha Hirani
This meta-analysis aimed to compare the effectiveness of high statin monotherapy and a combination of statin and ezetimibe to prevent cardiovascular outcomes in patients with acute coronary syndrome (ACS). The study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We conducted comprehensive searches across online databases, including MEDLINE/ PubMed, EMBASE, and the Web of Science, to find the relevant articles from the databases' inception to 10 Feb 2024...
March 2024: Curēus
https://read.qxmd.com/read/38600858/mediterranean-diet-for-cardiovascular-disease-an-evidence-mapping-study
#40
REVIEW
Zi-Ling Cai, Liao-Yao Wang, Bing-Yue Zhang, Ai-Song Zhu
OBJECTIVE: This study aimed to evaluate the methodological quality of existing meta-analyses (MAs) and the quality of evidence for outcome indicators to in order to provide an updated overview of the evidence concerning the therapeutic efficacy of the Mediterranean diet (MD) for various types of Cardiovascular diseases (CVD). DESIGN: We conducted comprehensive searches of PubMed, Cochrane Library, and Embase databases. The quality of the MAs was assessed using the A Measurement Tool to Assess Systematic Reviews 2(AMSTAR 2) checklist, while the Grading of Recommendations Assessment, Development and Evaluation (GRADE) evidence evaluation system was employed to evaluate the quality of evidence for significant outcomes...
April 11, 2024: Public Health Nutrition
keyword
keyword
75702
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.